Original Article
Copyright ©2010 Baishideng. All rights reserved.
World J Gastroenterol. Aug 21, 2010; 16(31): 3888-3896
Published online Aug 21, 2010. doi: 10.3748/wjg.v16.i31.3888
Glucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients
Jessica Mwinyi, Christa Wenger, Jyrki J Eloranta, Gerd A Kullak-Ublick
Jessica Mwinyi, Christa Wenger, Jyrki J Eloranta, Gerd A Kullak-Ublick, Division of Clinical Pharmacology and Toxicology, University Hospital, CH-8091 Zurich, Switzerland
Author contributions: Kullak-Ublick GA, Eloranta JJ and Wenger C designed the study; Wenger C and Eloranta JJ performed the laboratory experiments; Mwinyi J performed the sequence and statistical analysis; Mwinyi J, Eloranta JJ and Kullak-Ublick GA wrote the manuscript.
Supported by The Swiss IBD Cohort Study (SNF Grant 33CSC0-108792); the Swiss National Science Foundation (Grant 32-120463/1); the Zurich University Research Priority Programme “Integrative Human Physiology” (ZIHP); the Center of Clinical Research at the University Hospital Zurich; and the Novartis Foundation for Biomedical Research
Correspondence to: Gerd Kullak-Ublick, Professor, Division of Clinical Pharmacology and Toxicology, University Hospital, CH-8091 Zurich, Switzerland. gerd.kullak@usz.ch
Telephone: +41-44-2552068 Fax: +41-44-2554411
Received: March 11, 2010
Revised: May 14, 2010
Accepted: May 21, 2010
Published online: August 21, 2010
Core Tip